Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients.Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.
Abstract
Purpose: Vitamin D deficiency is common in Crohn disease (CD). The aim of the study was to examine the prevalence of vitamin D deficiency and evaluate the association between vitamin D status and growth outcome in Korean pediatric CD patients.Methods: In this retrospective study, 17 children younger than 18 years old diagnosed with CD were enrolled and their serum 25-hydroxy vitamin D (25[OH]D) was checked between 2011 and 2015. We categorized the patients into two groups, Group 1 and Group 2. Group 1 included patients with serum 25(OH)D levels below 10 ng/mL, and Group 2 was for patients with a 25(OH)D serum levels between 10 ng/mL and 30 ng/mL. The z-scores for height (Htz), weight (Wtz), and body mass index (BMIz) were measured at baseline, 6 months, and 12 months. Results: The mean serum 25(OH)D levels of the total 65 CD patients and 17 enrolled patients were 15.64±6.9 ng/mL and 13.1±5.1 ng/mL , respectively. There was no correlation at the beginning of the study between vitamin D level and growth parameters (Htz, Wtz, BMIz) or other variables including laboratory data and Pediatric Crohn Disease Activity Index. The Htz, Wtz, and BMIz in Group 1 showed no significant improvement at 6 months and 12 months follow-up. In Group 2, Wtz and BMIz showed significant improvements sustained until 12 months of follow-up. Htz showed no significant improvement at 6 months but there was significant improvement at 12 months. Conclusion: It seems that baseline vitamin D status affects growth outcome in pediatric CD.
참고문헌 (24)
- Vortia E, "The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients", Curr Opin Pediatr, 23, pp.545~551 (2011)
- Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)
- Thia KT, "An update on the epidemiology of inflammatory bowel disease in Asia", Am J Gastroenterol, 103, pp.3167~3182 (2008)
- Leong RW, "The epidemiology and phenotype of Crohn's disease in the Chinese population", Inflamm Bowel Dis, 10, pp.646~651 (2004)
- Alhagamhmad MH, "An update of the role of nutritional therapy in the management of Crohn's disease", J Gastroenterol, 47, pp.872~882 (2012)
- Lee JJ, "Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score", Inflamm Bowel Dis, 16, pp.1669~1677 (2010)
- Shamir R, "Nutritional aspects in inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 48(Suppl 2), pp.S86~S88 (2009)
- Sawczenko A, "Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease", Pediatrics, 118, pp.124~129 (2006)
- Theodoratou E, "Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials", BMJ, 348, pp.g2035~ (2014)
- Rosen CJ, "Clinical practice. Vitamin D insufficiency", N Engl J Med, 364, pp.248~254 (2011)
- Holick MF, "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 96, pp.1911~1930 (2011)
- Holick MF, "Vitamin D deficiency", N Engl J Med, 357, pp.266~281 (2007)
- Choi HS, "Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008", J Clin Endocrinol Metab, 96, pp.643~651 (2011)
- Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease:the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)
- Ulitsky A, "Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life", JPEN J Parenter Enteral Nutr, 35, pp.308~316 (2011)
- Tajika M, "Risk factors for vitamin D deficiency in patients with Crohn's disease", J Gastroenterol, 39, pp.527~533 (2004)
- Andreassen H, "Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease", Scand J Gastroenterol, 33, pp.1087~1093 (1998)
- Pappa HM, "Vitamin D status in children and young adults with inflammatory bowel disease", Pediatrics, 118, pp.1950~1961 (2006)
- Pappa HM, "Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 53, pp.361~364 (2011)
- Laakso S, "Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients", Calcif Tissue Int, 91, pp.121~130 (2012)
- Mora JR, "Vitamin effects on the immune system: vitamins A and D take centre stage", Nat Rev Immunol, 8, pp.685~698 (2008)
- Jørgensen SP, "Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study", Aliment Pharmacol Ther, 32, pp.377~383 (2010)
- Ananthakrishnan AN, "Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease", Inflamm Bowel Dis, 19, pp.1921~1927 (2013)
- Zator ZA, "Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases", JPEN J Parenter Enteral Nutr, 38, pp.385~391 (2014)